Publications by authors named "Josie Silvaroli"

Glomerular filtration rate (GFR) is the main functional index of kidney health and disease. Currently, no methods are available to directly measure tubular mass and function. Here, we report a serendipitous finding that the in vitro cell viability dye resazurin can be used in mice as an exogenous sensor of tubular function.

View Article and Find Full Text PDF

Unlabelled: Although the primary elimination pathway for most tyrosine kinase inhibitors (TKI) involves CYP3A4-mediated metabolism, the mechanism by which these agents are brought into hepatocytes remains unclear. In this study, we optimized and validated a competitive counterflow (CCF) assay to examine TKIs as substrates of the hepatic uptake transporter OATP1B1. The CCF method was based on the stimulated efflux of radiolabeled estradiol-17β-glucuronide under steady-state conditions in HEK293 cells engineered to overexpress OATP1B1.

View Article and Find Full Text PDF

Acylaminoindazole-based inhibitors of CDKL2 were identified via analyses of cell-free binding and selectivity data. Compound was selected as a CDKL2 chemical probe based on its potent inhibition of CDKL2 enzymatic activity, engagement of CDKL2 in cells, and excellent kinome-wide selectivity, especially when used in cells. Compound was designed as a negative control to be used alongside compound in experiments to interrogate CDKL2-mediated biology.

View Article and Find Full Text PDF

The biology of the cyclin-dependent kinase-like (CDKL) kinase family remains enigmatic. Contrary to their nomenclature, CDKLs do not rely on cyclins for activation and are not involved in cell cycle regulation. Instead, they share structural similarities with mitogen-activated protein kinases and glycogen synthase kinase-3, although their specific functions and associated signaling pathways are still unknown.

View Article and Find Full Text PDF

Acylaminoindazole-based inhibitors of CDKL2 were identified via analyses of cell-free binding and selectivity data. Compound was selected as a CDKL2 chemical probe based on its potent inhibition of CDKL2 enzymatic activity, engagement of CDKL2 in cells, and excellent kinome-wide selectivity, especially when used in cells. Compound was designed as a negative control to be used alongside compound in experiments to interrogate CDKL2-mediated biology.

View Article and Find Full Text PDF
Article Synopsis
  • Szeto–Schiller-31 (SS-31) provides protection against mitochondrial dysfunction, particularly during acute kidney injury (AKI), and requires the function of a protein called phospholipid scramblase 3 (PLSCR3).
  • Researchers performed extensive screenings and experiments to identify SS-31's targets, concluding that PLSCR3 is crucial for its protective effects while noting that deleting the PLSCR3 gene negates these benefits during AKI.
  • The study highlights PLSCR3's role in kidney function and its increased expression in AKI patients, suggesting its importance as a potential therapeutic target for kidney protection.
View Article and Find Full Text PDF

Pathological loss-of-function mutations in cyclin-dependent kinase-like 5 () cause CDKL5 deficiency disorder (CDD), a rare and severe neurodevelopmental disorder associated with severe and medically refractory early-life epilepsy, motor, cognitive, visual, and autonomic disturbances in the absence of any structural brain pathology. Analysis of genetic variants in CDD has indicated that CDKL5 kinase function is central to disease pathology. encodes a serine-threonine kinase with significant homology to GSK3β, which has also been linked to synaptic function.

View Article and Find Full Text PDF

Pathological loss-of-function mutations in cyclin-dependent kinase-like 5 ( ) cause CDKL5 deficiency disorder (CDD), a rare and severe neurodevelopmental disorder associated with severe and medically refractory early-life epilepsy, motor, cognitive, visual and autonomic disturbances in the absence of any structural brain pathology. Analysis of genetic variants in CDD have indicated that CDKL5 kinase function is central to disease pathology. encodes a serine-threonine kinase with significant homology to GSK3b, which has also been linked to synaptic function.

View Article and Find Full Text PDF

Despite mediating several essential processes in the brain, including during development, cyclin-dependent kinase-like 5 (CDKL5) remains a poorly characterized human protein kinase. Accordingly, its substrates, functions, and regulatory mechanisms have not been fully described. We realized that availability of a potent and selective small molecule probe targeting CDKL5 could enable illumination of its roles in normal development as well as in diseases where it has become aberrant due to mutation.

View Article and Find Full Text PDF

Transcriptional profiling studies have identified several protective genes upregulated in tubular epithelial cells during acute kidney injury (AKI). Identifying upstream transcriptional regulators could lead to the development of therapeutic strategies augmenting the repair processes. SOX9 is a transcription factor controlling cell-fate during embryonic development and adult tissue homeostasis in multiple organs including the kidneys.

View Article and Find Full Text PDF

Despite mediating several essential processes in the brain, including during development, cyclin-dependent kinase-like 5 (CDKL5) remains a poorly characterized human protein kinase. Accordingly, its substrates, functions, and regulatory mechanisms have not been fully described. We realized that availability of a potent and selective small molecule probe targeting CDKL5 could enable illumination of its roles in normal development as well as in diseases where it has become aberrant due to mutation.

View Article and Find Full Text PDF
Article Synopsis
  • Rbp2-/- mice are more susceptible to obesity and related metabolic issues compared to control mice, showing dysregulated levels of the hormone GIP.
  • Research indicates that RBP2 is largely present in enteroendocrine cells (EECs) responsible for producing hormones like GIP and glucagon-like peptide-1, and these cells also have the machinery to synthesize retinoic acid.
  • The study finds that Rbp2-/- mice have fewer total and GIP-positive EECs, suggesting that RBP2 and retinoic acid play important roles in the development and functioning of these hormone-producing cells.
View Article and Find Full Text PDF

Venetoclax, a BCL-2 inhibitor used to treat certain hematological cancers, exhibits low oral bioavailability and high interpatient pharmacokinetic variability. Venetoclax is commonly administered with prophylactic antifungal drugs that may result in drug interactions, of which the underlying mechanisms remain poorly understood. We hypothesized that antifungal drugs may increase venetoclax exposure through inhibition of both CYP3A-mediated metabolism and OATP1B-mediated transport.

View Article and Find Full Text PDF

Drug resistance and relapse are common challenges in acute myeloid leukemia (AML), particularly in an aggressive subset bearing internal tandem duplications (ITDs) of the FLT3 receptor (FLT3-ITD+). The tyrosine kinase inhibitor gilteritinib is approved for the treatment of relapse/refractory AML with FLT3 mutations, yet resistance to gilteritinib remains a clinical concern, and the underlying mechanisms remain incompletely understood. Using transcriptomic analyses and functional validation studies, we identified the calcium-binding proteins S100A8 and S100A9 (S100A8/A9) as contributors to gilteritinib resistance in FLT3-ITD+ AML.

View Article and Find Full Text PDF

A multitude of disease and therapy related factors drive the frequent development of kidney disorders in cancer patients. Along with chemotherapy, the newer targeted therapeutics can also cause kidney dysfunction through on and off-target mechanisms. Interestingly, among the small molecule inhibitors approved for the treatment of cancers that harbor BRAF-kinase activating mutations, vemurafenib can trigger tubular damage and acute kidney injury.

View Article and Find Full Text PDF
Article Synopsis
  • CRBP2 is a protein in the small intestine that helps with the uptake and metabolism of dietary retinoids, but recent findings indicate it also interacts with lipid molecules, suggesting a role in lipid metabolism and signaling.
  • Researchers conducted a high-throughput screening to identify CRBP2's interactions with various bioactive lipids, discovering its selective affinity for certain monoacylglycerols (MAGs) that are rich in polyunsaturated fatty acids.
  • The study also detailed specific amino acids in CRBP2 that enhance its ability to bind with MAGs, providing insights into how this protein may regulate lipid homeostasis differently than the more retinoid-specific CRBP1.
View Article and Find Full Text PDF

Lipids secreted by the meibomian glands (MGs) of the eyelids are essential to the protection of the eye's surface. An altered meibum composition represents the primary cause of evaporative dry eye disease (DED). Despite the critical importance of the meibum, its biosynthetic pathways and the roles of individual lipid components remain understudied.

View Article and Find Full Text PDF
Article Synopsis
  • Retinol-binding protein 2 (RBP2) is important for absorbing dietary retinoids in the small intestine, and its absence in mice leads to increased body weight, impaired glucose metabolism, and higher liver triglycerides as they age.
  • These issues are also seen in young mice on a high-fat diet, indicating a broader metabolic impact.
  • RBP2 acts as a binding protein for monoacylglycerols (MAGs), engaging with the endocannabinoid 2-AG, which suggests that RBP2 plays a crucial role in regulating energy balance and signaling beyond its function in retinoid absorption.
View Article and Find Full Text PDF
Article Synopsis
  • - Cellular retinol-binding proteins (CRBPs) are crucial for transporting and managing vitamin A in the body, making them potential targets for treating various health issues.
  • - Abnormal cannabidiol (abn-CBD) has been identified as a specific inhibitor of CRBP1, with studies showing how it binds effectively to the protein and alters retinoid flow in living organisms.
  • - Research demonstrates that abn-CBD can protect eyes from light damage in mice, suggesting it could lead to new treatments for diseases linked to retinoid metabolism imbalances.
View Article and Find Full Text PDF

Vitamin A (all-trans-retinol) is metabolized to the visual chromophore (11-cis-retinal) in the eyes and to all-trans-retinoic acid, a hormone like compound, in most tissues. A key enzyme in retinoid metabolism is lecithin:retinol acyltransferase (LRAT), which catalyzes the esterification of vitamin A. The importance of LRAT is indicated by pathogenic missense and nonsense mutations, which cause devastating blinding diseases.

View Article and Find Full Text PDF

The biochemical pathway that gives onions their savor is part of the chemical warfare against microbes and animals. This defense mechanism involves formation of a volatile lachrymatory factor (LF) ((Z)-propanethial S-oxide) that causes familiar eye irritation associated with onion chopping. LF is produced in a reaction catalyzed by lachrymatory factor synthase (LFS).

View Article and Find Full Text PDF

The esterification of alcohols with fatty acids is a universal mechanism to form inert storage forms of sterols, di- and triacylglycerols, and retinoids. In ocular tissues, formation of retinyl esters is an essential step in the enzymatic regeneration of the visual chromophore (11--retinal). Acyl-CoA wax alcohol acyltransferase 2 (AWAT2), also known as multifunctional -acyltransferase (MFAT), is an integral membrane enzyme with a broad substrate specificity that has been shown to preferentially esterify 11--retinol and thus contribute to formation of a readily available pool of retinoids in the eye.

View Article and Find Full Text PDF

The ability to store and distribute vitamin A inside the body is the main evolutionary adaptation that allows vertebrates to maintain retinoid functions during nutritional deficiencies and to acquire new metabolic pathways enabling light-independent production of 11- retinoids. These processes greatly depend on enzymes that esterify vitamin A as well as associated retinoid binding proteins. Although the significance of retinyl esters for vitamin A homeostasis is well established, until recently, the molecular basis for the retinol esterification enzymatic activity was unknown.

View Article and Find Full Text PDF
Article Synopsis
  • Cellular retinol-binding protein 1 (CRBP1) is crucial for the transport and metabolism of vitamin A, but its ligand uptake and release process is not fully understood.* -
  • The study presents the first structure of CRBP1 without a ligand and detailed structures when bound to retinoids, revealing significant changes in protein structure upon binding.* -
  • The conformational flexibility of apo-CRBP1 allows it to interact with ligands, while the more stable structure of the holoprotein ensures safe transport of vitamin A.*
View Article and Find Full Text PDF